{"nct_id":"NCT01685255","title":"A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy","status":"TERMINATED","status_verified_date":"2019-03","start_date":"2012-08","start_date_type":null,"primary_completion_date":"2014-10-23","primary_completion_date_type":"ACTUAL","completion_date":"2014-10-23","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["INCY"]}